263 related articles for article (PubMed ID: 21389785)
1. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity.
Kabacik S; Ortega-Molina A; Efeyan A; Finnon P; Bouffler S; Serrano M; Badie C
Cell Cycle; 2011 Apr; 10(7):1152-61. PubMed ID: 21389785
[TBL] [Abstract][Full Text] [Related]
2. Chek2ing out the p53 pathway: can Puma lead the way?
Hollstein M; Hupp T
Cell Cycle; 2011 May; 10(10):1524. PubMed ID: 21478674
[No Abstract] [Full Text] [Related]
3. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
Lin K; Adamson J; Johnson GG; Carter A; Oates M; Wade R; Richards S; Gonzalez D; Matutes E; Dearden C; Oscier DG; Catovsky D; Pettitt AR
Clin Cancer Res; 2012 Aug; 18(15):4191-200. PubMed ID: 22675167
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
6. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
7. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
8. ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.
Dujka ME; Puebla-Osorio N; Tavana O; Sang M; Zhu C
Oncogene; 2010 Feb; 29(7):957-65. PubMed ID: 19915617
[TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
[TBL] [Abstract][Full Text] [Related]
10. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
11. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
12. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.
Lavin MF; Khanna KK
Int J Radiat Biol; 1999 Oct; 75(10):1201-14. PubMed ID: 10549596
[TBL] [Abstract][Full Text] [Related]
13. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
[TBL] [Abstract][Full Text] [Related]
14. Activation of interferon-stimulated genes by gamma-ray irradiation independently of the ataxia telangiectasia mutated-p53 pathway.
Sugihara T; Murano H; Nakamura M; Ichinohe K; Tanaka K
Mol Cancer Res; 2011 Apr; 9(4):476-84. PubMed ID: 21357441
[TBL] [Abstract][Full Text] [Related]
15. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
Maclean KH; Dorsey FC; Cleveland JL; Kastan MB
J Clin Invest; 2008 Jan; 118(1):79-88. PubMed ID: 18097482
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
[TBL] [Abstract][Full Text] [Related]
17. Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.
Gaul L; Mandl-Weber S; Baumann P; Emmerich B; Schmidmaier R
J Cancer Res Clin Oncol; 2008 Feb; 134(2):245-53. PubMed ID: 17653574
[TBL] [Abstract][Full Text] [Related]
18. [Interaction between ATM and radiation-activated phosphorylation of P53 and P21].
Luo JL; Cao JP; Zhu W; Feng S; Sheng FJ; Zhu CY; Zheng SY
Ai Zheng; 2005 Sep; 24(9):1059-63. PubMed ID: 16159425
[TBL] [Abstract][Full Text] [Related]
19. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.
Pang LY; Scott M; Hayward RL; Mohammed H; Whitelaw CB; Smith GC; Hupp TR
Cell Cycle; 2011 Mar; 10(6):932-50. PubMed ID: 21368573
[TBL] [Abstract][Full Text] [Related]
20. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]